Seres Therapeutics, Inc. Share Price
NASDAQ: MCRBHealthcare
Live Seres Therapeutics, Inc. Share Price Chart
O H L
Seres Therapeutics, Inc. Performance Overview
Days Range
▼
$4.06Low
$4.06High
Markets Today
| Previous Close | $4.10 |
|---|---|
| Open | $4.06 |
| Volume | 14,809 |
| Day's Range | $4.06 - $4.06 |
| 52W Range | $4.18 - $29.98 |
| Market Cap | $42.29 M |
Historical Performance
| 1M Returns | -5.53 |
|---|---|
| 3M Returns | -37.97 |
| 6M Returns | -54.60 |
| 1Y Returns | -77.26 |
| 5Y Returns | -97.12 |
| 10Y Returns | -98.37 |
Seres Therapeutics, Inc. Fundamentals
| Market Cap | $42.29 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $789.00 K |
| ROE TTM | 0.20 |
| EPS TTM | $-2.33 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.20 |
| EBITDA | $-89.84 M |
| Profit Margin | 721.93 |
| Market Cap | $42.29 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $789.00 K |
| ROE TTM | 0.20 |
| EPS TTM | $-2.33 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.20 |
| EBITDA | $-89.84 M |
| Profit Margin | 721.93 |
Seres Therapeutics, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $351.00 K | $438.00 K | $358.00 K | $736.00 K |
| Gross Profit + | $0 | $0 | $351.00 K | $438.00 K | $358.00 K | $736.00 K |
| Operating Income | -$27.24 M | -$24.88 M | -$22.48 M | -$19.38 M | -$20.91 M | -$21.27 M |
| EBITDA | -$26.16 M | -$23.82 M | -$21.43 M | -$18.42 M | -$20.13 M | -$14.80 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $1.08 M | $1.06 M | $1.04 M | $954.00 K | $781.00 K | $6.48 M |
| Income Before Tax | $32.68 M | -$19.86 M | $8.20 M | -$15.34 M | -$19.91 M | $4.58 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | $32.68 M | -$19.86 M | $8.20 M | -$15.34 M | -$19.91 M | $4.58 M |
| Net Profit Margin | - | - | 2337.32% | -3501.14% | -5562.29% | 622.42% |
Seres Therapeutics, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $9.00 K | $9.00 K | $9.00 K | $10.00 K | $10.00 K | $10.00 K |
| Reserve & Surplus | -$945.42 M | -$965.27 M | -$957.07 M | -$972.40 M | -$992.32 M | -$987.74 M |
| Non-Current Liabilities | $82.39 M | $79.91 M | $77.35 M | $74.65 M | $71.78 M | $47.02 M |
| Current Liabilities | $31.32 M | $30.94 M | $22.43 M | $19.32 M | $19.34 M | $20.03 M |
| Total Liabilities | $113.72 M | $110.85 M | $99.78 M | $93.97 M | $91.12 M | $67.05 M |
| Fixed Assets | $10.55 M | $9.62 M | $8.58 M | $7.63 M | $6.85 M | $5.80 M |
| Current Assets | $66.08 M | $48.69 M | $51.53 M | $49.38 M | $31.84 M | $42.35 M |
| Total Assets | $164.18 M | $143.80 M | $143.47 M | $138.19 M | $117.62 M | $101.59 M |
Seres Therapeutics, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $32.68 M | -$19.86 M | $8.20 M | -$15.34 M | -$19.91 M | $4.58 M |
| Operating Cash Flow | $26.91 M | -$13.29 M | $2.21 M | -$14.71 M | -$16.36 M | -$22.39 M |
| Investing Cash Flow | -$34.00 K | -$181.00 K | -$8.00 K | $181.00 K | $0 | $14.00 K |
| Financing Cash Flow | $1.18 M | $0 | $61.00 K | $12.66 M | $428.00 K | $1.72 M |
| Change in Cash | $28.06 M | -$13.47 M | $2.26 M | -$1.87 M | -$15.93 M | -$20.66 M |
Seres Therapeutics, Inc. Return Calculator
The Seres Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$282
Invested Amount$10,000
Est. Returns$-9,718
About Seres Therapeutics, Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Popular Stocks
FAQs
What is the share price of Seres Therapeutics, Inc. today?
Seres Therapeutics, Inc. (MCRB) share price as of September 18, 2026 is $4.02. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Seres Therapeutics, Inc.?
Yes, Indian Investors can invest in the Seres Therapeutics, Inc. (MCRB) Share by opening an international trading account with Angel One.
How can I purchase Seres Therapeutics, Inc. shares in India?
Purchasing Seres Therapeutics, Inc. (MCRB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Seres Therapeutics, Inc. (MCRB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Seres Therapeutics, Inc.?
Yes, you can purchase fractional shares of Seres Therapeutics, Inc. (MCRB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Seres Therapeutics, Inc.?
The market capitalization of Seres Therapeutics, Inc. on September 18, 2026, is $42.29 M.
In which sector Seres Therapeutics, Inc. belongs?
Seres Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Seres Therapeutics, Inc. stocks?
In order to invest in Seres Therapeutics, Inc. (MCRB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
